CONNECTA Therapeutics
Has an LEI
Lately:1 news story in 90 daysFollow changes →
Facts
as of Nov 17, 2026ABOUT US CONNECTA Therapeutics S.L. is a clinical-stage biotech company pioneering first-in-class neuroplasticity modulators to address unmet CNS medical needs in central nervous system (CNS) disorders.
- Legal name
- CONNECTA Therapeutics S.L.
- Employees
- 201-500estimated range
- Register numbers
- CIF B67481242
- Official records
- LEI 9598002EKHHKM4QRZ295
- Website
- connectatherapeutics.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
CONNECTA Therapeutics S.L.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Newsroom
Sep 102026
Blog
€3.1 million financing led by new investor Clave Capital, with participation from existing investors Proceeds will support completion of ongoing Phase IIa trial of CTH120 in Frag…
Jul 22026
Blog
Preclinical data highlight restoration of cognitive, behavioral and synaptic deficits in Fragile X syndrome models Barcelona, Spain - 2 July 2026 - CONNECTA Therapeutics, a clini…
Jun 102026
Blog
Builds on positive Phase I safety data and represents a key value-inflection milestone for the Company Advances a potentially disease-modifying approach for fragile X syndrome, a…
Sep 9, 20252025
Blog
CTH120 is a first-in-class neuroplasticity modulator with strong Phase I safety and tolerability data Awarded a €2.5M European Innovation Council (EIC) Accelerator grant to prepa…
Mar 4, 20252025
Blog
CONNECTA Therapeutics has announced positive results from its Phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics profile of its drug candidate CTH12…
Feb 18, 20252025
Blog
The European Innovation Council (EIC) announced yesterday that CONNECTA Therapeutics has been selected for grant and equity funding, following the last EIC Accelerator cut-off. C…
Sources: the outlets named on each headline, each story once
